Literature DB >> 11306952

Expression of the chemokine receptor CCR3 on human mast cells.

A de Paulis1, F Annunziato, L Di Gioia, S Romagnani, M Carfora, C Beltrame, G Marone, P Romagnani.   

Abstract

BACKGROUND: The aim of this study was to investigate whether human mast cells express functional active CCR3 receptors, which are activated by CC chemokines. These ligands include the CCR3-selective chemokines eotaxin and eotaxin-2 and the more promiscuous CC chemokines, MCP-4, MCP-3, MCP-2 and RANTES.
METHODS: Immunohistochemical analysis was performed on skin, gut and lung specimens. Double immunostaining was performed with anti-CCR3 and antitryptase, and anti-CCR3 and antichymase antibody (Ab) by using the avidin-biotin-peroxidase system with two different substrates. Mast cells were isolated and purified from human lung parenchyma (HLMC) by countercurrent elutriation followed by discontinuous Percoll density gradient. Flow-cytometric analysis of HLMC surface CCR3 expression was performed with the monoclonal Ab anti-CCR3 (7B11). Functional activation of HLMC was verified by the ability of cells to release histamine and/or migrate in response to eotaxin.
RESULTS: High percentages (>70%) of tryptase-positive cells showing CCR3 expression were found in the skin and in the intestinal submucosa, whereas much lower percentages (< or = 20%) were found in the intestinal mucosa and in the lung interstitium. Eotaxin (1-100 nM) neither induced histamine release from HLMC nor enhanced anti-IgE-induced histamine release. In contrast, eotaxin (10-100 nM) and RANTES (10-100 nM) induced HLMC chemotaxis in vitro. Preincubation of HLMC with antibody anti-CCR3 (5 microg/ml) before loading into the chemotaxis chamber abrogated chemotaxis elicited by eotaxin. Double immunostaining with anti-CCR3 and anti-chymase antibody showed that the vast majority of CCR3-expressing mast cells in the various human tissues examined were tryptase-chymase double-positive.
CONCLUSIONS: These results indicate that CCR3 is expressed on human mast cells and that these cells are attracted by CCR3-binding chemokines. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306952     DOI: 10.1159/000053694

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  18 in total

1.  CCL11 (Eotaxin-1) Levels Predict Long-Term Functional Outcomes in Patients Following Ischemic Stroke.

Authors:  Meaghan Roy-O'Reilly; Rodney M Ritzel; Sarah E Conway; Ilene Staff; Gilbert Fortunato; Louise D McCullough
Journal:  Transl Stroke Res       Date:  2017-06-21       Impact factor: 6.829

2.  Eotaxin-2 increased toll-like receptor 4 expression in endothelial cells in vitro and exacerbates high-cholesterol diet-induced atherogenesis in vivo.

Authors:  Chien-Sung Tsai; Chun-Yao Huang; Chien-Ho Chen; Yi-Wen Lin; Chun-Ming Shih; Nai-Wen Tsao; Kuang-Hsing Chiang; Chi-Yuan Lee; Hellen Jeng; Feng-Yen Lin
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Eotaxin-2 induces monocytic apoptosis in patients who have undergone coronary artery bypass surgery and in THP-1 cells in vitro regulated by thrombomodulin.

Authors:  Yi-Wen Lin; Chun-Yao Huang; Chun-Min Shih; Yi-Ting Tsai; Chin-Sheng Lin; Chih-Yuan Lin; Chi-Yuan Li; Shih-Hurng Loh; Cheng-Yen Lin; Feng-Yen Lin; Chien-Sung Tsai
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

4.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.

Authors:  Carine Blanchard; Ning Wang; Keith F Stringer; Anil Mishra; Patricia C Fulkerson; J Pablo Abonia; Sean C Jameson; Cassie Kirby; Michael R Konikoff; Margaret H Collins; Mitchell B Cohen; Rachel Akers; Simon P Hogan; Amal H Assa'ad; Philip E Putnam; Bruce J Aronow; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

5.  Airway mast cells in a rhesus model of childhood allergic airways disease.

Authors:  Laura S Van Winkle; Gregory L Baker; Jackie K W Chan; Edward S Schelegle; Charles G Plopper
Journal:  Toxicol Sci       Date:  2010-04-19       Impact factor: 4.849

6.  CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation.

Authors:  Weilie Ma; Paul J Bryce; Alison A Humbles; Dhafer Laouini; Ali Yalcindag; Harri Alenius; Daniel S Friend; Hans C Oettgen; Craig Gerard; Raif S Geha
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 7.  Regulation of G-protein-coupled signaling pathways in allergic inflammation.

Authors:  Kirk M Druey
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

8.  The function of CCR3 on mouse bone marrow-derived mast cells in vitro.

Authors:  Sarah J Collington; John Westwick; Timothy J Williams; Charlotte L Weller
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

9.  Prostaglandin I2 Suppresses Proinflammatory Chemokine Expression, CD4 T Cell Activation, and STAT6-Independent Allergic Lung Inflammation.

Authors:  Weisong Zhou; Jian Zhang; Kasia Goleniewska; Daniel E Dulek; Shinji Toki; Dawn C Newcomb; Jacqueline Y Cephus; Robert D Collins; Pingsheng Wu; Mark R Boothby; R Stokes Peebles
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

Review 10.  Pathophysiology of urticaria.

Authors:  Ana Hennino; Fréderic Bérard; Isabelle Guillot; Nathalie Saad; Auore Rozières; Jean-François Nicolas
Journal:  Clin Rev Allergy Immunol       Date:  2006-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.